Davoodi et al. reported that glypican-3 binds to and inhibits the dipeptidyl peptidase activity of DPP4 in the Simpson-Golabi-Behmel syndrome (29). This evidence concerns the gene GPC3 and Simpson-Golabi-Behmel syndrome.